Eukaryotic Pathogens Innovation Center (EPIC)
Statewide team lands five years of funding for biomedical research
EPIC researchers gain ground in the race to cure widespread parasitic infection
Pitted against parasites: Developing a creative way to turn a parasite’s own evolutionary adaptations against itself.
Past and future join as one at College of Science 2019 philanthropy reception
The Eukaryotic Pathogens Innovation Center (EPIC), founded in January 2013, is an interdisciplinary research cooperative at Clemson University. It stands at the forefront of biomedical research on eukaryotic pathogens, which are the causative agents of some of the most devastating and intractable diseases of humans including malaria, amoebic dysentery, sleeping sickness, Chagas disease, and fungal meningitis. Globalization has resulted in an increase in such infections in the US and many eukaryotic pathogens are also classified as bioterrorism agents and/or neglected tropical diseases (NTDs). The global importance of these pathogens is what motivates our faculty members, who have established a lengthy track record of major contributions in this area of research.
- Jessica Jones Recognized with Best Poster Presentation Award
- Phillip Burkhardt Selected to Attend 2nd Annual NSUR
- Diana Nguyen Selected as Scholar by National Institutes of Health Undergraduate Scholarship Program
- 4th Annual Cellular Biology of Eukaryotic Pathogens Meeting
- Morris Lab Paper Accepted for Publication